# 90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients

> **NCT06151457** · NA · UNKNOWN · sponsor: **General Hospital of Ningxia Medical University** · enrollment: 80 (estimated)

## Conditions studied

- Adverse Effect

## Interventions

- **DRUG:** Alpha-Agonist
- **DRUG:** α-adrenergic receptor agonist

## Key facts

- **NCT ID:** NCT06151457
- **Lead sponsor:** General Hospital of Ningxia Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2025-01-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06151457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06151457, "90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06151457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*